The synthesis and biological evaluation of para-substituted phenolic N-alkyl carbamates as endocannabinoid hydrolyzing enzyme inhibitors The endocannabinoids constitute an important class of endogenous lipids that serve as chemical messengers both in the brain and the periphery. The two main endocannabinoids, N-arachidonoylethanolamine (anandamide, AEA, 1) [1] and 2-arachidonoylglycerol (2-AG, 2) [2, 3] , bind to and activate both cannabinoid receptors, CB 1 [4, 5] and CB 2 [6] , that bind also exogenous cannabinoids like D 9 -tetrahydrocannabinol (D 9 -THC, 3) (Fig. 1) . The activation of CB 1 and CB 2 receptors by cannabinoids induces several beneficial therapeutic effects such as pain relief and reduction of inflammation [7] . However, the cannabinergic effects of AEA and 2-AG remain weak in vivo owing to their rapid inactivation by the hydrolytic enzymes fatty acid amide hydrolase (FAAH, FAAH-1) [8] and monoglyceride lipase (MGL) [9] , respectively. FAAH is the main metabolizing enzyme responsible for the AEA degradation. AEA is also hydrolyzed by other enzymes such as FAAH-2, a second FAAH isoform [10] , and N-acylethanolaminehydrolyzing acid amidase (NAAA) [11] . FAAH has a broad substrate selectivity, and it has been well characterized both pharmacologically and biochemically. Therefore, several FAAH inhibitors have been developed (see for review Ref. [12] ), including various fatty acid derivatives [13] [14] [15] [16] [17] , and non-lipid inhibitors such as a-keto heterocycles [18] [19] [20] , carbamate derivatives [21] [22] [23] [24] [25] , (thio)-hydantoins [26] and most recently, selective piperidine/piperazine ureas [27, 28] . Probably, the most well-studied FAAH inhibitors are the carbamate-based 3 0 -carbamoylbiphenyl-3-yl ester (4, URB597) ( Fig. 2) [21, 29] and the a-keto heterocycle-based 7-phenyl-1-(5-(pyridin-2-yl)oxazol-2-yl)heptan-1-one (OL-135) [19] , which have gained considerable promise for treating anxiety, inflammation, and pain [7, 19, [29] [30] [31] .
Besides being the main metabolizing enzyme for AEA, FAAH is also able to hydrolyze 2-AG [32] . However, the main enzyme responsible for the inactivation of 2-AG in the brain has been suggested to be MGL (EC 3.1.1.23) [9, 33, 37] , although other hydrolytic activities may also contribute to the metabolism [34] [35] [36] [37] . MGL is a serine hydrolase, which hydrolyzes medium-and long-chain fatty acid esters such as 2-AG and its analogue 2-oleoylglycerol (2-OG) [9, 38] .
In contrast to FAAH, there is neither a 3D structure available for MGL nor the exact information of amino acid residues in the vicinity of the active site of the enzyme. Therefore, the design of potent and selective MGL inhibitors has remained a challenging Author's accepted manuscript, published in European Journal of Medicinal Chemistry 44 (2009) [2994] [2995] [2996] [2997] [2998] [2999] [3000] [3001] [3002] [3003] [3004] [3005] [3006] [3007] [3008] task so far. However, very recently, during revision of this manuscript, Long et al. published a potent and selective MGL inhibitor called JZL184, which was shown to raise brain 2-AG in mice by eight-fold without altering AEA [39] . The other known potent inhibitors of this enzyme are compounds like hexadecylsulfonylfluoride (HDSF), methyl arachidonylfluorophosphonate (MAFP), and diisopropyl fluorophosphate [9, 34, 38] that are highly unselective and not useful for in vivo studies. The same is true for bis(dimethylthio)mercury, the contaminant responsible for the MGL inhibitory effects originally ascribed to 6-methyl-2-[(4-methylphenyl)amino]-4H-3,1-benzoxazin-4-one (URB754) [40] . Additionally, the N-biphenyl-3-cyclohexylcarbamic acid cyclohexyl ester (5, URB602) ( Fig. 2) was originally suggested to be a selective MGL inhibitor [41] , although its selectivity data has recently been questioned [42, 43] . Sulfhydryl-reactive compounds such as p-chloromercuribenzoic acid, N-ethylmaleimide (NEM) [9, 44, 45] and disulfiram [46] inhibit MGL activity, indicating the presence of an essential sulfhydryl group at the active site of the enzyme. In a series of sulfhydryl-specific maleimide derivatives, N-arachidonylmaleimide (NAM, 6) ( Fig. 2 ) was found to be a potent inhibitor of MGL, inhibiting 2-AG hydrolysis in rat cerebellar membranes with an IC 50 value of 140 nM [45] , a result confirmed using human recombinant MGL (hrMGL), and 2-OG as substrate [46] . Despite containing a highly reactive maleimide group, NAM has been shown to exhibit rather high selectivity for MGL relative to other brain serine hydrolases [37] . Other approaches have also yielded compounds that inhibit MGL, but with potencies in the micromolar range [47] . For current knowledge of MGL and the inhibitors developed so far, see reviews [12, 48, 49] .
The carbamate compound SPB01403 (7) (Fig. 3) , found in virtual screening as reported in our previous study, could inhibit both FAAH (IC 50 ; 0.52 mM) and MGL (IC 50 ; 30 mM) [50] . This observation raises the possibility that O-phenyl carbamate-based compounds can be optimized to give compounds with potent effects toward both FAAH and MGL, and that these compounds can be used in vivo to investigate the therapeutic potential of a concomitant blockade of hydrolysis of both AEA and 2-AG. Consequently, the structurally similar compound, SEW01169 (8) (Fig. 3 ), was purchased and tested for its FAAH and MGL inhibitory activity, and it was found to be slightly more potent FAAH inhibitor (IC 50 ; 0.16 mM) than 7, albeit less potent inhibitor against 2-AG hydrolysis with remaining MGL activity 54% at 100 mM compound concentration in rat cerebellar membranes. Compound 8 was also tested against human recombinant MGL (hrMGL), and it was found to inhibit 2-OG hydrolysis with an IC 50 value of 43 mM. Herein, we present the synthesis and biological evaluation of a series of phenolic N-alkyl carbamates derived from 7 and 8, and their structure-activity relationships (SAR) for the inhibition of endocannabinoid hydrolyzing enzymes, FAAH and MGL.
Chemistry
The synthesis of compounds is outlined in Schemes 1 and 2. The majority of the carbamates were obtained by treating various phenols with suitable alkyl isocyanates in the presence of triethylamine; the O-phenyl carbamates 9-29, 30 [51] , 31-33, 35 [53, 54] , 37-39 [55] , 40 [52, 55] , 41, 42 [53, 56] , 43 [57] , 44, 46, and 48-51 were prepared from the corresponding phenols, and in the case of N-phenyl carbamate 52, from cyclohexanol by a route described in Schemes 1 and 2. On the contrary, the O-phenyl carbamates 34 [52, 55, [58] [59] [60] and 36 [61] were prepared from 4-nitrophenyl chloroformate and the appropriate amine, yielding the desired products in 32-99% yield, with shorter reaction time than in the isocyanate method. The O-phenyl N-n-hexylcarbamates 45 and 47 were prepared from the corresponding methyl benzoates (Scheme 2). 4-(4,5-Dihydrothiazol-2-yl)phenol 54 [62] for the preparation of the carbamates 9-20 was prepared by simply heating the mixture of cysteamine and 4-cyanophenol (Scheme 1). Unfortunately this method was not suitable for the preparation of 4-(4,5-dihydrooxazol-2-yl)phenol 56 for the synthesis of the carbamates 21-24, thus it was obtained by the reaction described by Witte and Seeliger [63] (Scheme 1). For this purpose the hydroxyl group of 4-cyanophenol was protected as the benzyl ether (55) [64] . (1,2,3-Thiadiazol-4-yl)phenols 58a-c [65, 66] for the preparation of the carbamates 25-29 and 48-51 [67] were obtained from phenyl ketones by the Hurd-Mori reaction via hydrazones 57a-c [65, 66] (Scheme 1). The same method was applied in the preparation of 4-(1,2,3-thiadiazol-4-yl)aniline hydrochloride (58d) for the synthesis of the urea compound 53 (Scheme 1). 
Biological testing
The inhibitory potencies against AEA hydrolysis (by FAAH) of all the prepared compounds 9-53, and the leads 7 and 8 were determined in rat brain homogenate [50] . The compounds 7-10, 13-26, 28, 31-33, 36, 42, 43, 49, 51, 52 , and 53 were tested for their ability to inhibit 2-AG hydrolysis (by MGL) in rat cerebellar membranes [34] , while the MGL inhibitory potencies of the compounds 8, 11, 12, 26, 27, 29-31, 34, 35, 37-41, 44-48, 50 , and 51 were evaluated in hrMGL (Cayman Chemical), using tritium-labelled oleoylglycerol as substrate. In order to demonstrate the comparability of the two MGL methods used, the compounds 8, 26, 31 and 51 were tested in both assays. Moreover, inhibition of FAAH and MGL by reference compounds, FAAH inhibitor URB597 (4) and previously reported selective MGL inhibitor URB602 (5), were evaluated. The results of reference compounds showed good correlation with the ones reported in the literature [29, 42, 43] .
Results and discussion

Structural optimization of the lead SPB01403 (7)
A series of N-alkyl derivatives of the lead SPB01403 (7) with dihydrothiazoline (9-20, Table 1 ) or dihydrooxazoline moiety (21-24, Table 2 ) at para-position in the phenyl ring were prepared and tested for their FAAH and MGL inhibitory activities.
Among the dihydrothiazoline moiety containing open chain N-alkyl carbamates (7, 9-12) the chain length was the main factor Scheme 1. Synthesis of compounds 9-29, 48-51 and 53-58a-d. Reagents and conditions: (a) 2-aminoethanethiol, 100 C, 88%; (b) i) BnBr, K 2 CO 3 , KI, acetone, reflux, 98%, ii) 2-aminoethanol, PhCl, reflux, 50%; (c) H 2 , Pd/C, ethanol, rt, 75%; (d) ethyl carbazate, p-TsOH, toluene/ethanol, Dean-Stark, 69-100%; (e) SOCl 2 , rt, 43-85%; (f) RNCO, Et 3 N, toluene, rtreflux, 20-100%; wherein R ¼ Et, n-Pr, n-Hex, dodecyl, t-Bu, c-pentyl, c-Hex, Bn, 2-MeBn, 4-MeBn, 4-MeOBn, phenethyl.
Scheme 2. Synthesis of compounds 30-47 and 52. Reagents and conditions: (a) RNCO, Et 3 N, toluene, rt-reflux, 50-100%; wherein R ¼ n-Bu, n-Hex, c-Hex, dodecyl; (b) RNH 2 , pyridine, CH 2 Cl 2 , reflux, 32-99%; wherein R ¼ n-Bu, c-Hex; (c) methanol, H 2 SO 4 , reflux, 100%.
affecting the inhibition potencies toward both enzymes; with short N-ethyl group (9) the IC 50 values against FAAH was 15 mM, whereas with longer N-n-hexyl (11) and N-dodecyl (12) Replacement of the open chain N-alkyl groups with bulky N-tert-butyl group (13) reduced the inhibitory potencies toward FAAH and MGL (IC 50 s; 7.0 mM and >100 mM, respectively). This is probably due to steric hindrance near the carbamate group, thus reducing crucial interactions within the active sites of the enzymes.
The differences in the FAAH and MGL inhibition potencies among the other dihydrothiazoline derivatives with different N-alkyl groups (14) (15) (16) (17) (18) (19) (20) were mainly not notable. However, with cycloalkyl and benzylic groups (14) (15) (16) (17) (18) (19) complete MGL inhibition was not observed, even at the highest concentrations tested (1 mM). This remaining enzyme activity can be explained by an additional enzyme activity distinct from MGL or by low aqueous solubility of these compounds. An interesting observation concerning the FAAH inhibition was that the N-2-methylbenzyl derivative (17) (IC 50 ; 0.062 mM) was more potent FAAH inhibitor than the other derivatives with cyclic or benzylic N-alkyl moiety (14-16, 18, 19 ) (IC 50 s; 0.10-0.32 mM).
With respect to dihydrooxazoline derivatives 21-24 (Table 2) , no clear difference in the inhibition potencies toward either FAAH or MGL was seen when comparing the results to those of the corresponding dihydrothiazoline derivatives 7, 14, 17, and 18. However, like in the series of dihydrothiazoline substituted N-cycloalkyl or N-benzylic derivatives, the N-2-methylbenzyl derivative (23) (IC 50 ; 0.034 mM) displayed better inhibitory potency against FAAH than the other N-alkyl derivatives in the dihydrooxazoline series (IC 50 s; 0.10-0.18 mM).
Structural optimization of the lead SEW01169 (8)
After establishing the optimal N-alkyl groups for the inhibition of FAAH and MGL within the dihydrothiazol-2-yl and dihydrooxazol-2-yl substituted O-phenyl carbamates, a series of SEW01169 (8) derivatives with various and selected N-alkyl groups were prepared (Table 3) .
Not surprisingly, in this series of 1,2,3-thiadiazol-4-yl substituted derivatives (8, (25) (26) (27) (28) (29) , the length and the shape of the N-alkyl group had a similar effect on the inhibitory potencies against both enzymes, FAAH and MGL, as it had in the previous series. Thus, by replacing the N-n-butyl chain of 8 by N-n-hexyl (25) the inhibitory potencies toward FAAH and MGL were improved (IC 50 s; 0.019 and 11 mM, respectively). Furthermore, the most potent inhibitor in this series with N-dodecyl moiety (26) inhibited FAAH with an IC 50 value of 0.012 mM. Moreover, hydrolysis of 2-AG in rat brain membranes as well as hrMGL mediated 2-OG hydrolysis However, the compounds with N-cyclopentyl (27) , N-cyclohexyl (28) and N-benzyl (29) moieties were more potent FAAH inhibitors than the corresponding dihydrothiazoline derivatives 14-16, indicating that FAAH inhibitory activity could be affected by the type of heterocycle. This effect was not seen for MGL.
The effect of para-substituents with different electronic properties
The catalytic site serine -OH of FAAH [68] and MGL is expected to have a strong interaction with the reactive carbonyls of the ligands. Therefore, we decided to study whether the electronic properties of the para-substituent in O-phenyl carbamates have an effect on the FAAH and MGL inhibitory activities. The presumption that electronwithdrawing groups in para-position on the phenyl ring would increase the electrophilicity of the carbonyl carbon prompted us to prepare a series of N-alkyl carbamates with various electron-withdrawing and electron-donating substituents (Table 4) . Methoxy carbonyl (30) (31) (32) (33) , nitro (34) (35) (36) , cyano (37 and 38) , and bromine (39) were selected as electron-withdrawing (EWG), and methoxy (40) and methyl (41) as electron-donating groups (EDG). The neutral effect was evaluated with the unsubstituted O-phenyl carbamates 42 and 43.
As evident from the results presented in Table 4 , the EWG and EDG had opposite effects on the inhibitory potencies against MGL. EWG (methoxycarbonyl, nitro, and cyano) substituted compounds 30-39 maintained the potencies against MGL similar to those of the corresponding N-alkyl derivatives presented in Tables 1-3 , whereas EDG (methoxy and methyl) substituted compounds 40 and 41 had clearly diminished inhibition potencies. However, differences in inhibitory potencies against FAAH were hardly notable when comparing the results of EWG-substituted N-n-butyl derivatives 30, 34, and 37 with that of corresponding methoxy-substituted 40. On the contrary, within N-n-hexyl derivatives EWG-substituted 31, 35, 38, and 39 were more potent than methyl-substituted 41.
As observed in the series of the derivatives of 7 and 8, the FAAH and MGL inhibitory potencies were enhanced by increasing the length of the N-alkyl group. The same was true in this series; for example, the N-dodecyl derivative with electron-withdrawing methoxy carbonyl group (33) [21] . This observed increase in FAAH inhibition potencies might be due to more flexible and lipophilic nature of N-n-hexyl and N-dodecyl groups. The similar observation can be seen when comparing the results of N-cyclohexyl (32, 36) and/or N-n-butyl derivatives (30, 34, 37, and 40) to those of other N-n-hexyl (31, 35, 38, 39, and 41) and N-dodecyl derivatives (33) .
Altogether, these results indicate that FAAH inhibition potencies might be more dependent on the N-alkyl moiety than the electronic properties of the para-substituent, while MGL inhibition potencies can be enhanced by EWG at para-position in the phenyl ring as well. In addition, a few derivatives of 31 with EDG (methoxy, 44; methyl, 45; tert-butyl, 47) or EWG (iodine, 46) at the ortho-position in the phenyl ring were prepared to study the effects of steric and electronic properties of ortho-substituents to MGL and FAAH inhibitory activity. As evident from Table 5 , the ortho-methoxy substituent (44) improved the inhibitory potency toward both FAAH and hrMGL when compared to the results obtained with the compound 31 without any ortho-substituent. This might be due to favourable interactions between the oxygen atom in the methoxy group and the active site residues of the enzymes. Me-or I-substitution (45 and 46) did not have a significant effect on the affinity toward either FAAH or MGL. However, a bulky tert-butyl substituent (47) diminished the affinity toward these enzymes notably, which could be due to steric hindrance.
Effect of the meta-and ortho-substitution in the phenyl ring
To support our previous results of the influence of the substituent's position in the phenyl ring on the FAAH and MGL inhibitory activities (i.e. para-substitution is more favourable to the MGL inhibitory activities) [22] , meta-and ortho-analogues of 8 and its most potent derivative with N-dodecyl group (26) were prepared and tested (Table 6) .
In our previous studies, meta-substituted carbamate URB597 (4) was found to inhibit AEA hydrolysis with an IC 50 value of 0.0038 mM [50] , which is comparable to the previously reported IC 50 value of 0.0046 mM [29] , and only 30% inhibition of 2-AG hydrolysis in rat brain membranes was evident at 1 mM [34] . Compound 48, the ortho-substituted analogue of 8, did not inhibit either of the enzymes; only 27% inhibition of MGL was observed at 100 mM, and no inhibition of FAAH could be detected at 0.1 mM. On the contrary, the meta-substituted analogue 49 inhibited FAAH with an IC 50 value of 0.0069 mM. However, only 13% inhibition of MGL by 49 was observed at 100 mM concentration, which is similar to the results obtained with the ortho-substituted 48 and the para-substituted 8.
The meta-substituted compound 51 with a more lipophilic These data support the previous findings that para-substitution is more favourable to MGL inhibition, whereas meta-substitution is favourable for FAAH [22] .
The effectiveness of O-phenyl carbamate structure on MGL and FAAH inhibition
To investigate the effectiveness of the O-phenyl carbamate structure on MGL and FAAH inhibition, two N-phenyl carbamates (URB602 (5) and 52) and a urea compound 53 were tested. URB602 has been reported to be a selective inhibitor of MGL [41] , although in our previous study it was shown to be totally inactive against 2-AG hydrolysis in rat brain membranes at 1 mM [42] . Moreover, in the present study 30% inhibition of hrMGL was seen at 100 mM.
URB602 has also been reported to inhibit AEA hydrolysis by rat brain membranes (IC 50 ; 17 mM) [43] . In the present study URB602 inhibited FAAH with an IC 50 value of 108 mM. Consequently, compounds 52 and 53 lacking O-phenyl carbamate structure showed no inhibition activity toward MGL, and only 9% inhibition of FAAH at 0.1 mM was observed with these compounds. These results establish that the O-phenyl carbamate structure in the compounds investigated in the present study is essential for the inhibitory activities toward both enzymes, FAAH and MGL. The results are presented in Table 7 .
Reversibility
Compound 26 was investigated in more detail with respect to reversibility of FAAH and MGL inhibition. Reversibility was determined by measuring the recovery of FAAH and MGL enzymatic activity after a rapid and large dilution (500-fold) of the enzymeinhibitor complexes.
In the reversibility studies the compound 26 was found to inhibit both FAAH and hrMGL in an irreversible manner ( Fig. 4a and  b) . Inhibition of FAAH by URB597 (4) was shown to be irreversible and by 1-(oxazolo [4,5-b] pyridin-2-yl)-1-oxo-dodecane (CAY10435) [18] inhibition was reversible (Fig. 4a ), as has been described in the Enzyme activity was measured at the indicated time-points after 500-fold dilution of the enzyme-inhibitor complex. For a fully reversible compound, the dilution should result in d.p.m. values approaching those seen with vehicle (DMSO) alone. The data represent the means and s.e.m. from three independent experiments performed in duplicate. literature [18, 68] . Inhibition of hrMGL by MAFP was also shown to be irreversible (Fig. 4b) .
The effects in intact cells
Compound 26 was investigated to its effects in intact cells. The effects of a compound upon FAAH activity in intact cells can be determined by measuring either the URB597 sensitive uptake of AEA or by following its hydrolysis [69] . In these assays 26 was found to be efficacious, and the IC 50 value for the inhibition of the hydrolysis by intact RBL2H3 cells was 0.082 mM (Figs. 5 and 6 ).
Compound 26 also reduced the hydrolysis of 2-AG by these cells at concentrations !0.03 mM (Fig. 6) . However, this presumably reflects a FAAH component of 2-AG hydrolysis in these cells, since URB597 (4) also produced a partial inhibition of the 2-AG hydrolysis (data not shown).
Conclusions
In the present paper, we have developed a novel series of parasubstituted phenolic N-alkyl carbamates as inhibitors of FAAH and MGL. The compounds inhibited FAAH with IC 50 values in the nM range, whereas inhibition of MGL required concentrations three orders of magnitude higher. The FAAH inhibition potencies of the prepared para-substituted carbamates were highly affected by the shape and lipophilicity of the N-alkyl group; compounds with flexible and lipophilic N-n-hexyl and N-dodecyl groups were most potent inhibitors of FAAH.
Due the importance of FAAH as a potential target for the development of new therapeutical agents, these novel para-substituted carbamates present a useful extension to the previously reported meta-substituted carbamates as FAAH inhibitors [21] [22] [23] [24] [25] , and may be useful for the development of new classes of FAAH inhibitors. Furthermore, this data may be valuable, together with that of the compounds reported earlier by us [22] , in the derivation of 3D-QSAR models for the FAAH inhibition by O-phenyl carbamates.
Moreover, O-phenyl carbamates have been previously described extensively as potent FAAH inhibitors, but less is known about their ability to inhibit MGL. The present results indicate that in the compounds investigated in the present study the O-aryl carbamate structure, with an acyclic or a cyclic electron-withdrawing moiety at the para-position in the phenyl ring, and a lipophilic N-alkyl group are essential for MGL inhibitory activity. These novel compounds, albeit not being potent and selective, may be helpful in further design of compounds with more potent inhibitory activities against MGL.
Experimental protocols
Chemistry
Commercially available starting materials were used without further purification. SEW01169 and SPB01403 were purchased from Maybridge Chemicals LTD. URB597, URB602, CAY10435, and MAFP were purchased from Cayman Chemical. Solvents were distilled or dried with 4 Å molecular sieves prior to use. All dry reactions were performed under argon in flame-or oven-dried glassware. Analytical thin-layer chromatography was carried out on Merck A mixture of 4-cyanophenol (1.20 g, 10 mmol, 100 mol%) and 2-aminoethanethiol (1.20 g, 15 mmol, 150 mol%) was heated at 100 C for 10 min and cooled to rt. The resulting yellow solid was suspended in water (8 mL) and the mixture was acidified with 1 M HCl (8 mL To a refluxing solution of 4-cyanophenol (6.0 g, 50 mmol, 100 mol%), K 2 CO 3 (13.8 g, 100 mmol, 200 mol%), and KI (4.15 g, 25 mmol, 50 mol%) in acetone (100 mL) was added BnBr (9.4 g, 55 mmol, 110 mol%) and the mixture was refluxed for 2 h. The ) . These values give an IC 50 value of 0.082 mM (constraining ''top'' and ''bottom'' values of the analysis to 100 and 0%, respectively). mixture was cooled to rt, poured into water (250 mL) and extracted with EtOAc (200 mL þ 100 mL). The organic phase was washed with brine (150 mL), dried (Na 2 SO 4 ), evaporated to dryness and the resulting residue crystallized from EtOAc/hexane giving in 4-benzyloxybenzonitrile as colourless needles (10.2 g, 97%).
ZnCl 2 (0.65 g, 4.8 mmol, 10 mol%) was melted by flame heating under high vacuum and cooled to rt under argon atmosphere. 4-Benzyloxy-benzonitrile (10.2 g, 48.7 mmol, 100 mol%) and chlorobenzene (180 mL) were added and the mixture was heated to reflux. Ethanolamine (14.5 mL, 245 mmol, 500 mol%) was added and the mixture was refluxed for 24 h. Another portion of ethanolamine (29 mL,1000 mol%) was added and the mixture refluxed for additional 24 h and partitioned between water (500 mL) and EtOAc (500 mL). The organic phase was washed with brine (200 mL), dried (Na 2 SO 4 ), filtered and evaporated to dryness. The residue was purified by FC (eluent 1-5% MeOH in CH 2 Cl 2 ) and recrystallized (EtOAc:hexane) to give 55 (6.16 g, 50%) as white crystals: mp 136.7-137. 
4-(4,5-Dihydrooxazol-2-yl)phenol (56) [70]
Compound 55 (2.0 g, 7.9 mmol, 100 mol%) was dissolved in EtOH (50 mL), and the mixture was degassed with argon. 5% Pd/C (330 mg, 0.16 mmol, 2 mol%) was added and the mixture was degassed with hydrogen. The mixture was stirred under H 2 at rt for 90 min and filtered through a pad of celite and evaporated to dryness. Crystallization of the residue from EtOH gave 56 (0.96 g, 75%) as a white solid: mp 209.1-210. [65] A mixture of 4-hydroxyacetophenone (4.1 g, 30 mmol, 100 mol%), ethyl carbazate (3.3 g, 31.5 mmol, 105 mol%) and p-TsOH (280 mg, 1.5 mmol, 5 mol%) in dry toluene (100 mL) was refluxed for 2 h with a Dean-Stark trap. The solvent was removed under reduced pressure, and the crude residue was washed with diethyl ether to [66] A mixture of 2-hydroxyacetophenone (3.6 ml, 4.1 g, 30 mmol, 100 mol%), ethyl carbazate (3.3 g, 31.5 mmol, 105 mol%) and p-TsOH (280 mg, 1.5 mmol, 5 mol%) in ethanol (100 mL) was refluxed for 22 h and kept overnight in the refrigerator. The precipitate was filtered off with suction and washed with diethyl ether to give 57c (5.24 g, 78%) as light yellow needles: 1 (45) 4-Hydroxy-3-methyl benzoic acid (152 mg, 100 mol%) in methanol (10 mL) and a catalytic amount of conc. H 2 SO 4 was refluxed overnight and the remaining methanol was evaporated giving 177 mg (100%) of the corresponding methyl ester. This was used directly without further purification to the preparation of the title compound.
To a mixture of 4-hydroxy-3-methyl benzoic acid methyl ester (83 mg, 0.5 mmol, 100 mol%) and a catalytic amount of Et 3 N in dry toluene (2 mL) was added hexyl isocyanate (80 mL, 110 mol%). After gently refluxing overnight the reaction mixture was cooled and the solvent evaporated. Purification by FC (eluent EtOAc/PE, 1:1) and crystallization (EtOAc/hexane, 1:2) gave 45 (81 mg, 55%) as white crystals: mp 52.4-53. Four-week-old male Wistar rats were used in these studies. All animal experiments were approved by the local ethics committee. The animals lived in a 12-h light/12-h dark cycle (lights on at 0700 h), with water and food available ad libitum. The rats were decapitated eight hours after lights on (1500 h), the whole brains were removed, dipped in isopentane on dry ice and stored at À80 C.
The membranes were prepared as previously described [71] [72] [73] . Briefly, cerebella were dissected and homogenized in nine volumes of ice-cold 0.32 M sucrose with a glass Teflon homogenizer. The crude homogenate was centrifuged at low speed (1000 Â g for 10 min at 4 C) and the pellet was discharged. The supernatant was centrifuged at high speed (100,000 Â g for 10 min at 4 C). The pellet was resuspended in ice-cold deionized water and washed twice, repeating the high-speed centrifugation. Finally, the membranes were resuspended in 50 mM Tris-HCl, pH 7.4 with 1 mM EDTA and aliquoted for storage at À80 C until use. The protein concentration of the final preparation was measured by the Bradford method [74] .
In vitro assay for MGL activity in rat cerebellar membranes
The assay for MGL has been described previously [34] . Briefly, experiments were carried out with preincubations (80 mL, 30 min at 25 C) containing 10 mg membrane protein, 44 mM Tris-HCl (pH 7.4), 0.9 mM EDTA, 0.5% (wt/vol) BSA and 1.25% (vol/vol) DMSO as a solvent for inhibitors. The preincubated membranes were kept at 0 C just prior to the experiments. The incubations (90 min at 25 C) were initiated by adding 40 mL of the preincubated membrane cocktail, giving a final volume of 400 mL. The final volume contained 5 mg membrane protein, 54 mM Tris-HCl (pH 7.4), 1.1 mM EDTA, 100 mM NaCl, 5 mM MgCl 2 , 0.5% (wt/vol) BSA and 50 mM of 2-AG. At time-points of 0 and 90 min, 100 ml aliquots were removed from the incubation, acetonitrile (200 mL) was added to stop the enzymatic reaction, and the pH of the samples was simultaneously decreased with phosphoric acid (added to acetonitrile) to 3.0, in order to stabilize 2-AG against chemical acyl migration reaction to 1(3)-AG. The samples were centrifuged at 23,700g for 4 min at rt prior to HPLC analysis of the supernatant.
HPLC method for in vitro assay for MGL
The analytical HPLC was performed as previously described [34] . Briefly, the analytical HPLC system consisted of a Merck Hitachi (Hitachi Ltd., Tokyo, Japan) L-7100 pump, D-7000 interface module, L-7455 diode-array UV detector (190-800 nm, set at 211 nm) and L-7250 programmable autosampler. The separations were accomplished on a Zorbax SB-C18 endcapped reversed-phase precolumn (4.6 Â 12.5 mm, 5 mm) and column (4.6 Â 150 mm, 5 mm) (Agilent, U.S.A). The injection volume was 50 ml. A mobile phase mixture of 28% phosphate buffer (30 mM, pH 3.0) in acetonitrile was used at a flow rate of 2.0 ml min
